[Pulmonary surfactant and the immune system]

Area of Science:

• Pulmonary immunology
• Biochemistry of lung surfactants

Background:

• Natural lung surfactant, a lipid-protein complex, possesses potential immunogenic properties.
• Therapeutic and prophylactic use of exogenous lung surfactants requires understanding their immune system interactions.

Purpose of the Study:

• To review existing data on the immunogenicity and immunological functions of exogenous lung surfactants.
• To explore the role of surfactant in the lung's local immune response and host defense.

Main Methods:

• Review of existing literature on surfactant immunogenicity and immune interactions.
• Analysis of studies detecting immune complexes and antibodies in neonates treated with exogenous surfactants.
• Examination of research on surfactant's direct effects on bacteria and immune cells.

Main Results:

• Detection of surfactant-antisurfactant immune complexes and antibodies in some newborns with respiratory distress syndrome.
• Inconclusive evidence from several studies regarding the formation of specific antibodies against surfactant proteins B or C after bovine surfactant treatment.
• Evidence suggests surfactant directly impacts bacterial defense and modulates immune cell activity in the alveoli.

Conclusions:

• While short-term surveys show limited specific symptoms associated with surfactant antibodies, long-term follow-up is needed, especially for neonates with new lung diseases.
• Lung surfactant plays a multifaceted role in pulmonary immunity, including direct pathogen defense and immune response modulation.
• Further research is essential to fully elucidate the immunological aspects of lung surfactant.